Aker BioMarine scientists and members of the company's Science Advisory Board met to discuss future studies and krill sustainability.
Reporting on a recent meeting between its R&D scientists and its Science Advisory Board, Aker BioMarine (Oslo, Norway) says it is planning a future study on krill for joint health and inflammation for later this year. The krill ingredients supplier plans to incorporate krill oils and powders in the human study.
Sustainability of krill resources was also discussed at the recent meeting. Researchers concluded that there is still no sign of krill catch affecting any populations of krill predators.
PLT Health Solution's Bosewellia serrata extract granted updated license by Health Canada
August 27th 2024The Natural and Non-Prescription Health Products Directorate (NNPHD) of Health Canada has granted PLT Health Solutions an updated license to market its AprèsFlex 5-Day Joint Support Ingredient in Canada.